Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8730803 | Revista de Gastroenterología de México | 2018 | 50 Pages |
Abstract
The aim of the Mexican Consensus on the Treatment of Hepatitis C was to develop clinical practice guidelines applicable to Mexico. The expert opinion of specialists in the following areas was taken into account: gastroenterology, infectious diseases, and hepatology. A search of the medical literature was carried out on the MEDLINE, EMBASE, and CENTRAL databases through keywords related to hepatitis C treatment. The quality of evidence was subsequently evaluated using the GRADE system and the consensus statements were formulated. The statements were then voted upon, using the modified Delphi system, and reviewed and corrected by a panel of 34 voting participants. Finally, the level of agreement was classified for each statement. The present guidelines provide recommendations with an emphasis on the new direct-acting antivirals, to facilitate their use in clinical practice. Each case must be individualized according to the comorbidities involved and patient management must always be multidisciplinary.
Keywords
SofosbuvirvelpatasvirLNHFDAVHBVIHledipasvirLDVElbasvirInterferon-free regimensSOFEASLAASLDRBVVELAADCHCvHCEMAdcvIDSALinfoma no HodgkinRVsConsensusEBVinterferonIFNAFPdaclatasvirConsensoRibavirinRibavirinaFood and Drug AdministrationAntivirales de acción directadirect-acting antiviral agentsPCRVirus de inmunodeficiencia humanaVirus de la hepatitis BVirus de la hepatitis CCarcinoma hepatocelularVARGrazoprevirMELD
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
I. Aiza-Haddad, A. Ballesteros-Amozurrutia, O.D. Borjas-Almaguer, M. Castillo-Barradas, G. Castro-Narro, N. Chávez-Tapia, R.A. Chirino-Sprung, L. Cisneros-Garza, M. Dehesa-Violante, J. Flores-Calderón, A. Flores-Gaxiola, I. GarcÃa-Juárez,